Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BYMedicina (Kaunas, Lithuania)

The LAI–Oral Antipsychotic Efficacy–Effectiveness Paradox in Schizophrenia

  • Kaloyan Stoychev1
  • Sara Begum1
  • Sheraz Nazar2
  1. 1Research Institute, Department of Psychiatry and Medical Psychology, , 5800 Pleven, Bulgaria
  2. 2Department of Psychiatry and Medical Psychology, , 5800 Pleven, Bulgaria;
Read full textPDFCite

Related

  1. Genetic Polymorphisms and Hemostatic-Inflammatory Biomarkers in Schizophrenia Patients Receiving Antipsychotic Treatment
    Dita Hasni, Debie Anggraini, Mutiara Anissa +1
    Psychopharmacology BulletinPeer-reviewedLicence not statedFull textPsychiatry & mental healthPMC
  2. Baseline severity of positive and negative symptoms predicts relapse in opposing directions among placebo-treated schizophrenia patients: analysis of five placebo-controlled, antipsychotic withdrawal, relapse-prevention trials
    J. Rabinowitz, M. Davidson, C. U. Correll +5
    medRxivPreprintCC BY-NDFull textPsychiatry & mental healthmedRxiv
  3. Metabolic syndrome in stable long-term antipsychotic monotherapy and polypharmacy among patients with schizophrenia: a real-world comparative study.
    Haluk Usta, Didem Beşikci Keleş
    Frontiers in psychiatryPeer-reviewedCC BYFull textPsychiatry & mental healthEurope PMCCrossref
  4. Hepato-Immune Crosstalk Underlies Antipsychotic-Associated Metabolic Dysregulation in Schizophrenia: Quercetin as a Therapeutic Candidate for High-Inflammatory Subtypes.
    Yi Yang, Bin Liu, Zhicheng Cao +10
    MetabolitesPeer-reviewedCC BYFull textPsychiatry & mental healthEurope PMC
  5. Sex differences in QTc prolongation and electrocardiographic changes before and after antipsychotic treatment of schizophrenia
    Xinwang Song, Fangcheng Fan, Jiaquan Liang
    Frontiers in PsychiatryPeer-reviewedCC BY 4.0Full textPsychiatry & mental healthCrossrefEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{stoychev2026laioral,
  title = {{The LAI–Oral Antipsychotic Efficacy–Effectiveness Paradox in Schizophrenia}},
  author = {Kaloyan Stoychev and Sara Begum and Sheraz Nazar},
  journal = {Medicina (Kaunas, Lithuania)},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13706815},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - The LAI–Oral Antipsychotic Efficacy–Effectiveness Paradox in Schizophrenia
AU  - Kaloyan Stoychev
AU  - Sara Begum
AU  - Sheraz Nazar
PY  - 2026
DA  - 2026/10/01
JO  - Medicina (Kaunas, Lithuania)
UR  - https://europepmc.org/article/PMC/PMC13706815
SN  - 1010-660X
SN  - 1648-9144
ER  -